“Don’t segregate the entrepreneurs, embrace them”

Posted on June 20, 2018 | Ashley Sheppard | 0 Comments

Mitacs 2018 Global Impact Entrepreneur award winner, Dr. Alli Murugesan. Dr. Murugesan is a senior scientist at the University of New Brunswick’s Reiman Cancer Research Laboratory and founder of Saint John-based BioHuntress Therapeutics, a company that is cutting the time to market from research to drug by creating an incubator within academia to encourage and support researchers in commercializing discovery breakthroughs. The first product being developed is a novel treatment for blood cancers that has been shown to target and kill cancer cells, including cells that have grown resistant to chemotherapy.

Taking ideas that were born in the lab and bringing them to the market has been a long-standing goal of Dr. Alli Murugesan. This goal has manifested in what is now BioHuntress Therapeutics, an incubator within academia that is meant to do just that.

Dr. Murugesan founded the company in 2016 while working on her postdoctoral fellowship with Mitacs Canada, a non-profit, national research program. It was after joking with a colleague about how ludicrous it would be to start a company that was capable of commercializing research quickly, that she decided to pursue it.

“The focus of academia is to publish,” says Dr. Murugesan. “Commercialization is not given much importance simply because it takes a long time, or you have to go out of your way to find the resources.”

With BioHuntress, Dr. Murugesan believes she is capable of being the resource that researchers need to go beyond publishing. Her discovery and development of this new business model is growing concurrently with her first medical breakthrough.

Dr. Murugesan partnered with medical oncologist and UNB professor Dr. Tony Reiman and Université de Moncton associate professor Dr. Mohamed Touaibia to create a nature-inspired compound that has the ability to kill blood cancer cells—even those resistant to chemotherapy.

BioHuntress is working on bringing this drug to market, seeking industry funding and investment to begin animal testing and phase one clinical trials.

A dedicated scientist who is passionate about research that serves the greater good, Dr. Murugesan’s vision and methodical follow-through has earned her national recognition, receiving the 2018 Mitacs Global Impact Entrepreneur Award.

BioHuntress’ next step is to establish its incubator where it can be most beneficial. The company is currently negotiating with the University of New Brunswick to provide them with a space in the Saint John campus. Dr. Murugesan expects this will be good for researchers and business students alike.

“If I could also be embraced by the School of Business at UNB, then it becomes an extremely interesting collaboration,” said Dr. Murugesan. “The potential talents from the business school could be involved in the long-term vision of BioHuntress.”

Innovation hubs like BioHuntress are not unheard of in larger universities. In fact, colleagues have suggested to Dr. Murugesan that she try and secure her company in a city with more demand; but, she has other plans.

“Everyone was telling me that I should go to Fredericton because that’s the innovation happening place,” said Dr. Murugesan. “And I said… ‘well it’s nice to hear that, but could Saint John have its own innovation hub too? Why should I move if there is potential here?’”

Dr. Murugesan isn’t quite sure what the future of BioHuntress entails. She just hopes to fulfill what it means to have a global impact. “All I could think about was that my idea was coming alive… and it looked beautiful.”

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment policy

Comments are moderated to ensure thoughtful and respectful conversations. First and last names will appear with each submission; anonymous comments and pseudonyms will not be permitted.

By submitting a comment, you accept that Atlantic Business Magazine has the right to reproduce and publish that comment in whole or in part, in any manner it chooses. Publication of a comment does not constitute endorsement of that comment. We reserve the right to close comments at any time.


With ABM

Help support the magazine and entrepreneurship in Atlantic Canada.


Stay in the Know

Subscribe Now

Subscribe to receive the magazine and gain access to exclusive online content.

    Your Cart
    Your cart is empty